aap completes sale of remaining stake in aap Joints GmbH
16. Dezember 2016 02:35 ET
|
aap Implantate AG
Final step on the way to a pure player in trauma aap Implantate AG ("aap") announces the successful completion of the sale of the remaining stake of 33% in aap Joints GmbH. The company fulfilled...
aap schließt Verkauf der verbliebenen Beteiligung an aap Joints GmbH ab
16. Dezember 2016 02:35 ET
|
aap Implantate AG
Letzter Schritt auf dem Weg zu einem Pure Player im Bereich Trauma Die aap Implantate AG ("aap") gibt bekannt, dass der Verkauf der verbliebenen Beteiligung in Höhe von 33 % an der aap Joints...
aap schließt Distributionsvertrag mit führendem Dienstleister im US-amerikanischen Gesundheitswesen
15. Dezember 2016 05:00 ET
|
aap Implantate AG
Weiterer wichtiger Fortschritt im Rahmen der angestrebten Vertriebsfokussierung auf etablierte Märkte Die aap Implantate AG ("aap") gibt den Abschluss eines Distributionsvertrags für ihre LOQTEQ®...
aap concludes distribution contract with leading US healthcare service provider
15. Dezember 2016 05:00 ET
|
aap Implantate AG
Further important progress in the aimed distribution focus on established markets aap Implantate AG ("aap") announces the conclusion of a distribution contract for its LOQTEQ® products with a...
aap: Umsatz und EBITDA in Q3/2016 im Rahmen der Guidance; Nordamerika-Umsatz in 9M/2016 über den Erwartungen; Wichtige Fortschritte beim Ausbau des LOQTEQ® Portfolios
14. November 2016 17:50 ET
|
AAP Implantate AG
Umsatz und EBITDA in Q3/2016 bei 2,9 Mio. EUR (Guidance: 2,5 Mio. EUR bis 4,0 Mio. EUR) und -1,8 Mio. EUR (Guidance: -2,0 Mio. EUR bis -1,2 Mio. EUR) EBITDA in Q3/2016 und im 9-Monatszeitraum durch...
aap: Q3/2016 sales and EBITDA within the guidance; North America sales in 9M/2016 above expectations; important progress in LOQTEQ® portfolio expansion
14. November 2016 17:50 ET
|
AAP Implantate AG
Sales and EBITDA in Q3/2016 at EUR 2,9 million (Guidance: EUR 2.5 million to EUR 4.0 million) and EUR -1.8 million (Guidance: EUR -2.0 million to EUR -1.2 million) EBITDA burdened by one-time...
aap Annual Financial Statements for 2011: 6% Sales Growth at Product Level With Strong EBITDA/EBIT Increase; Successful Launch of the LOQTEQ(R) System
30. März 2012 09:00 ET
|
aap Implantate AG
BERLIN, March 30, 2012 (GLOBE NEWSWIRE) -- aap Implantate AG (XETRA:AAQ), a global medical device company focused on innovative trauma products and biomaterials for the orthopaedic market, achieved...
aap Implantate AG Licenses Proprietary Biomaterials Product to a World Leading Medical Technology Company
29. März 2012 08:01 ET
|
aap Implantate AG
BERLIN, March 29, 2012 (GLOBE NEWSWIRE) -- aap Implantate AG (Frankfurt:AAQ), a global medical device company focused on innovative trauma products and biomaterials for the orthopaedic market,...
aap Implantate AG: New Date for the Annual Shareholders Meeting
15. Juli 2008 04:57 ET
|
aap Implantate AG
BERLIN, July 15, 2008 (PRIME NEWSWIRE) -- aap Implantate AG, a medical technology company listed on the Frankfurt Stock Exchange in the Prime Standard segment and active in medical biomaterials,...
aap Implantate AG Reports First-Half Year Organic Increase in Sales of 29 Percent
02. Juli 2008 12:37 ET
|
aap Implantate AG
BERLIN, July 2, 2008 (PRIME NEWSWIRE) -- aap Implantate AG, a medical technology company listed on the Frankfurt Stock Exchange in the Prime Standard segment and active in medical biomaterials,...